Acknowledgements
The author thanks Hadas Marcus for editing this article.
Financial & competing interests disclosure
The author is the inventor of a patent for antivirulence compounds to treat Staphylococcal and Streptococcal infections. The author is the founder of InVira Therapeutics, LLC (formerly Designer Drug Development, LLC). The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.